Cross-Border Surrogacy

March 29, 2017

Exploiting low income women as biological resources? Our globalised economy responds voraciously to biotech advances, but lax regulation risks turning the poor into biological resources to be used for profit

Quick Read

It is hard to recommend taking a 19-hour flight with a toddler to get a root canal with a straight face. But after going on just such a mission in December, I will aim to get all future dental work done in Thailand

Quick Read

A group of academic researchers has demanded an end to cancer medicines costing more than $100,000 a year and proposed a new model of low-cost drug development that would capitalize on recent advances in science

Quick Read

In 2017, the public support for transgender people is growing. Last August, nonpartisan independent research organization PRRI found that 72 percent of Americans favor LGBT nondiscrimination laws. But what good is support for if they can’t afford treatment? “This is my last resort, asking people for money,” Moog says

Quick Read

Overwhelmed counsellors and medical staff in Sierra Leone must contend with suspicion and a collapse in funding

Quick Read

Five years ago, Dr. Ira Kirschenbaum, an orthopedic surgeon in the Bronx who replaces more than 200 knees each year, would have considered it crazy to send a patient home the same day as a knee replacement operation

Quick Read

At many doctors’ offices and hospitals, a routine part of doing business these days is estimating patients’ out-of-pocket payments and trying to collect it up front

Quick Read

In this town, carved into the Appalachian mountains, in a state beset by hepatitis C rates seven times the national average, Harvoni and other new hepatitis C drugs remain largely out of reach. Over the past year, only 3 percent of the state’s Medicaid beneficiaries with the disease received treatment

Quick Read